BPC-157 body protection compound 157 is a synthetic peptide derived from a protein found in gastric juice
Furthermore, methylene blue induced a dose and time dependent generation of superoxide anion from rabbit pulmonary arterial smooth muscle cells, as evidenced from spectrophotometric determination of cytochrome c reduction
At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story
However, concerns remain regarding the long-term efficacy of iPS cell-derived RPE therapies, particularly due to the risk of oncogenic mutations and tumorigenesis reported in both preclinical models and clinical observations 47,48
Typical Cycle Lengths Mild to moderate injury (tendon, ligament, muscle): 24 weeks at 250500mcg per day Severe or post-operative injuries: 46 weeks, sometimes extending to 8 weeks Gastrointestinal issues (ulcers, IBS): 46 weeks at 250500mcg per day, oral or subQ Neurological repair or systemic inflammation: 46 weeks, systemic dosing recommended For most users, results begin to show within the first 710 days , especially in soft tissue or gut repair cases
These findings suggest significant metabolic modulation potential for further investigation
